Cypher Genomics Company
%20.jpg)
Cypher Genomics is a genome informatics company that develops and delivers automated human genome interpretation software solutions for clinical labs, pharmaceutical companies, and population genomics efforts. Their automated genomic interpretation platform allows clinical laboratories to tune Cypher Genomics' sensitivity and specificity profiles to develop molecular tests for diagnostic and prognostic use and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies. Cypher Genomics was founded by Ashley Van Zeeland in 2011 and is headquartered in La Jolla, California. It is now acquired by Human Longevity.
Last Funding Type:
Non-equity Assistance
Funding Status:
M&A
Headquarters:
San Diego, California, United States
Founded Date:
2011-01-01
Investor Type:
For Profit
Technology:
Biomarkers
Employee Number:
11-50
Investors Number:
1
Industry:
Biotechnology, Genetics, Health Care, Medical